Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Calluna Pharma As

Clinical trials sponsored by Calluna Pharma As, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug aims to halt lung decline in scarred lungs Results expected Nov 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

New drug aims to halt lung decline in scarred lungs

Disease control Ongoing

This trial tests an investigational drug called CAL101 in 150 adults with idiopathic pulmonary fibrosis, a disease that scars the lungs and makes breathing harder. Participants receive monthly IV infusions of CAL101 or a placebo for 6 months. The goal is to see if CAL101 can prev…

Phase 2 • Sponsor: Calluna Pharma AS • Aim: Disease control

Last updated Jun 27, 2026 12:24 UTC